Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · Real-Time Price · USD
0.605
+0.024 (4.15%)
At close: Nov 21, 2024, 4:00 PM
0.589
-0.016 (-2.71%)
After-hours: Nov 21, 2024, 4:59 PM EST

Elevation Oncology Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Equivalents
48.249.2645.92146.2879.41.74
Short-Term Investments
54.8733.8544.36---
Cash & Short-Term Investments
103.0783.1190.28146.2879.41.74
Cash Growth
8.73%-7.95%-38.28%84.24%4463.22%-
Prepaid Expenses
2.254.862.73.141.390.17
Total Current Assets
105.3287.9692.98149.4280.791.91
Other Intangible Assets
-0.060.10.040.06-
Other Long-Term Assets
0.941.071.090.030.07-
Total Assets
106.389.0994.16149.4980.911.91
Accounts Payable
2.630.516.365.655.680.46
Accrued Expenses
3.33.649.333.141.110.14
Total Current Liabilities
5.934.1515.698.796.790.6
Long-Term Debt
31.0230.1429.44---
Other Long-Term Liabilities
--00.010.02-
Total Liabilities
36.9534.2845.138.86.80.6
Common Stock
0.01000--
Additional Paid-In Capital
299.34250.83199.49195.880.070.01
Retained Earnings
-230.02-195.97-150.27-55.19-23.15-5.88
Treasury Stock
-0.1-0.06-0.04---
Comprehensive Income & Other
0.130.01-0.16---
Total Common Equity
69.3654.8149.03140.7-23.08-5.87
Shareholders' Equity
69.3654.8149.03140.774.111.32
Total Liabilities & Equity
106.389.0994.16149.4980.911.91
Total Debt
31.0230.1429.44---
Net Cash (Debt)
72.0552.9760.85146.2879.41.74
Net Cash Growth
11.11%-12.94%-58.41%84.24%4463.22%-
Net Cash Per Share
1.361.552.6212.06100.282.34
Filing Date Shares Outstanding
59.1248.6523.6623.210.80.74
Total Common Shares Outstanding
59.1242.4223.2923.210.80.74
Working Capital
99.483.8277.29140.64741.32
Book Value Per Share
1.171.292.116.06-28.83-7.89
Tangible Book Value
69.3654.7548.93140.66-23.14-5.87
Tangible Book Value Per Share
1.171.292.106.06-28.90-7.89
Source: S&P Capital IQ. Standard template. Financial Sources.